MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$46,892K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Maturities of marketable debt se...
Proceeds from atm offering
Depreciation and amortization
Others
Negative Cash Flow Breakdown
Net loss from continuing operati...
Purchases of marketable debt sec...
Prepaid expenses and other curre...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-
-
-80,751
-80,755
Net loss from continuing operations
-57,321
-76,059
-
-
Depreciation and amortization
12,315
12,799
13,663
14,168
Stock-based compensation
7,595
15,853
21,027
17,841
Goodwill impairment
-
-
0
0
Restructuring related impairment charges
-
-
0
-
Impairment of right-of-use asset
-
-
-
0
Non-cash customer consideration
-
-
0
-
(gain) loss on investments
1,987
-939
-
3,683
Loss on equity method investment
-4,673
-
0
-
Loss on deconsolidation of subsidiary
-
-
-
0
Loss on investments
-
-
-16,411
-
Change in fair value of notes receivable
0
-6,759
11,370
-5,685
Change in fair value of warrant liabilities
-
-
0
0
Change in fair value of contingent consideration
0
0
0
0
Loss on deconsolidation of subsidiaries
-
-
0
-
Impairment of long-lived assets
-
-
0
-
Deferred income tax benefit
-
-
-1,364
-
Loss on disposal of equipment
-
-
0
-
Non-cash lease expense
6,143
7,114
7,633
7,583
Non-cash in-process research and development
-
-
0
0
Accretion of discount on marketable securities
-29
120
888
2,502
Other non-cash activity
474
-185
-453
-1,565
Changes in operating assets and liabilities
-3,713
242
1,818
-757
Prepaid expenses and other current assets
6,705
-5,930
5,177
-2,202
Operating lease right-of-use assets
0
0
0
0
Other non-current assets
-48
-94
-334
-87
Accounts payable
-
-
-2,992
-
Accounts payable, accrued expenses and other current liabilities
3,944
-11,601
-6,615
22,116
Deferred revenue
-3,032
-2,606
-5,184
-3,533
Operating lease liabilities, current and non-current
-5,748
-4,995
-9,139
-7,155
Other non-current liabilities
-5,366
-758
7,004
-697
Net cash used in operating activities - continuing operations
-42,173
-46,433
-
-
Net cash used in operating activities - discontinued operations
-2,100
-253
-
-
Net cash used in operating activities - continuing operations
-44,273
-46,686
-47,678
-31,606
Deconsolidation of subsidiaries - cash
-
-
0
-
Purchases of marketable debt securities
44,284
83,161
16,792
81,706
Business acquisitions, net of cash acquired
-
-
0
0
Maturities of marketable debt securities
57,990
108,178
85,884
73,599
Purchases of notes receivable
-
-
0
-
Proceeds from sale of marketable debt securities
-
-
25,899
-64,958
Proceeds from sales of marketable equity securities
-
-
0
-
Proceeds from sale of equipment
-
-
574
0
Purchases of property and equipment
2,619
1,933
5
0
Other
0
-48
461
-249
Net cash provided by (used in) investing activities
11,087
23,132
95,099
-72,816
Proceeds from atm offering
17,049
-
9,152
10,317
Payment of issuance costs related to atm offering
560
-
985
355
Proceeds from exercise of stock options
-
-
0
0
Taxes paid related to net share settlement of equity awards
-
-
0
-
Principal payments on finance leases
0
19
25
24
Contingent consideration payment
-
-
0
0
Other
-
-
-
0
Payment of equity issuance costs and other
-
-
0
-
Net cash provided by (used in) financing activities
16,489
-19
8,142
9,938
Effect of foreign exchange rates on cash and cash equivalents
43
-129
-152
93
Net decrease in cash, cash equivalents and restricted cash
-16,654
-23,702
55,411
-94,391
Cash and cash equivalents, beginning of period
167,202
-
-
-
Restricted cash, beginning of period
45,169
-
-
-
Cash, cash equivalents and restricted cash, beginning of period
156,960
-
-
605,743
Cash and cash equivalents, end of period
84,535
-
-
-
Restricted cash, end of period
87,480
-
-
-
Cash, cash equivalents and restricted cash, end of period
172,015
-
-
156,960
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from atm
offering
$17,049K
Maturities of marketable
debt securities
$57,990K
Net cash provided by
(used in) financing...
$16,489K
(5506.23%↑ Y/Y)
Net cash provided by
(used in) investing...
$11,087K
(104.22%↑ Y/Y)
Effect of foreign
exchange rates on cash and...
$43K
(-83.46%↓ Y/Y)
Canceled cashflow
$560K
Canceled cashflow
$46,903K
Net decrease in
cash, cash...
-$16,654K
(95.30%↑ Y/Y)
Canceled cashflow
$27,619K
Payment of issuance
costs related to atm...
$560K
Purchases of marketable
debt securities
$44,284K
(-86.17%↓ Y/Y)
Purchases of property and
equipment
$2,619K
(-65.81%↓ Y/Y)
Net cash used in
operating activities -...
-$44,273K
(51.76%↑ Y/Y)
Depreciation and
amortization
$12,315K
(-60.48%↓ Y/Y)
Stock-based compensation
$7,595K
(-82.20%↓ Y/Y)
Non-cash lease expense
$6,143K
(-58.68%↓ Y/Y)
Loss on equity method
investment
-$4,673K
Accounts payable,
accrued expenses and...
$3,944K
(176.96%↑ Y/Y)
Changes in operating
assets and liabilities
-$3,713K
(-1001.21%↓ Y/Y)
Other non-current
assets
-$48K
(-138.40%↓ Y/Y)
Accretion of discount on
marketable securities
-$29K
Net cash used in
operating activities -...
-$42,173K
Net cash used in
operating activities -...
-$2,100K
Canceled cashflow
$38,460K
Net loss from
continuing operations
-$57,321K
Prepaid expenses and
other current assets
$6,705K
(195.11%↑ Y/Y)
Operating lease
liabilities, current and...
-$5,748K
(50.61%↑ Y/Y)
Other non-current
liabilities
-$5,366K
(-204.07%↓ Y/Y)
Deferred revenue
-$3,032K
(87.19%↑ Y/Y)
(gain) loss on
investments
$1,987K
(150.20%↑ Y/Y)
Other non-cash
activity
$474K
(1130.43%↑ Y/Y)
Buy us a coffee
Ginkgo Bioworks Holdings, Inc. (DNA)
Ginkgo Bioworks Holdings, Inc. (DNA)